BioLineRx Ltd. Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 2.01M1.90M0.45M0.11M0.02M0.02M0.47M2.28M1.63M1.01M2.16M4.80M28.94M
Cost of Revenue 0.86M1.14M1.59M1.00M1.35M1.69M1.36M0.86M0.84M1.00M6.46M25.27M23.61M
Gross Profit 2.01M1.74M0.28M-0.08M-0.13M0.02M0.47M2.28M1.63M1.01M2.16M1.11M19.68M
Operating items
Research & Development -17.23M-12.21M-11.87M-11.49M-11.18M-19.51M-19.81M-23.44M-18.17M-19.47M-17.63M-12.52M-9.15M
Selling, General & Administrative -3.76M-3.66M-3.80M-3.70M-3.98M-4.04M-4.43M-3.82M-3.91M-4.31M-5.07M-6.31M-6.32M
Operating Expenses -20.98M-15.87M-15.67M-15.19M-15.16M-23.55M-24.24M-27.25M-22.09M-23.77M-22.70M-18.83M-15.47M
Operating Income -21.85M-17.01M-17.25M-16.20M-16.51M-25.24M-25.61M-28.11M-22.93M-24.78M-29.16M-49.69M-20.41M
EBIT -21.85M-17.01M-17.25M-16.20M-16.51M-25.24M-25.61M-28.11M-22.93M-24.78M-29.16M-49.69M-20.41M
Non-operating items
Non Operating Investment Income 1.43M3.45M1.29M0.21M
Non Operating Income 1.06M1.16M3.06M1.45M0.21M
Net income details
EBT -19.84M-15.11M-16.81M-16.09M-16.49M-25.22M-25.13M-25.83M-21.30M-23.77M-27.00M-47.52M-11.29M
Profit After Tax -20.43M-17.02M-11.08M-14.40M-15.84M-24.35M-22.96M-25.45M-30.02M-27.05M-24.95M-60.61M-9.22M
Income from Continuing Operations -19.84M-15.11M-16.81M-16.09M-16.49M-25.22M-25.13M-25.83M-21.30M-23.77M-27.00M-47.52M-11.29M
Consolidated Net Income -19.84M-15.11M-16.81M-16.09M-16.49M-25.22M-25.13M-25.83M-21.30M-23.77M-27.00M-47.52M-11.29M
Income towards Parent Company -19.84M-15.11M-16.81M-16.09M-16.49M-25.22M-25.13M-25.83M-21.30M-23.77M-27.00M-47.52M-11.29M
Net Income towards Common Stockholders -19.84M-15.11M-16.81M-16.09M-16.49M-25.22M-25.13M-25.83M-21.30M-23.77M-27.00M-47.52M-11.29M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 12.36M18.37M24.15M39.12M54.82M101.87M105.06M148.92M296.51M709.12M922.87M929.06M1199.49M
EBITDA -20.43M-15.93M-13.91M-14.40M-15.84M-25.24M-25.61M-28.11M-22.93M-24.78M-29.16M-49.69M-20.41M